Benjamin Derman to Cell Transplantation
This is a "connection" page, showing publications Benjamin Derman has written about Cell Transplantation.
Connection Strength
0.056
-
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023 02; 24(2):139-150.
Score: 0.056